|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,330,696 |
|
|
Indirect Value
|
$12,970,625,176 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,052,955,872 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 46 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2011-11-23 |
4 |
B |
$25.71 |
$1,741,720 |
I/I |
67,427 |
6,783,952 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-27 |
4 |
S |
$1.28 |
$87,491 |
I/I |
(67,649) |
6,772,772 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-23 |
4 |
B |
$14.43 |
$980,509 |
I/I |
67,892 |
4,740,552 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$425,038 |
I/I |
68,006 |
539,130 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-12-18 |
4 |
B |
$3.56 |
$244,084 |
I/I |
68,463 |
3,386,599 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-25 |
4 |
B |
$1.60 |
$109,558 |
I/I |
68,534 |
5,784,851 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-10 |
4 |
B |
$29.86 |
$2,051,783 |
I/I |
68,681 |
234,540 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-07 |
4 |
B |
$26.14 |
$1,810,136 |
I/I |
69,198 |
5,924,995 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$1,140,774 |
I/I |
69,553 |
2,892,085 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-12-17 |
4 |
B |
$3.15 |
$231,313 |
I/I |
69,566 |
3,318,136 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-07 |
4 |
B |
$6.37 |
$478,630 |
I/I |
69,943 |
6,081,798 |
1.5 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-22 |
4 |
B |
$4.97 |
$348,509 |
I/I |
70,100 |
1,090,407 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-23 |
4 |
S |
$14.86 |
$1,042,485 |
I/I |
(70,150) |
2,933,021 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$271,511 |
I/I |
(70,159) |
1,522,015 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-01-09 |
4 |
B |
$8.95 |
$630,399 |
I/I |
70,449 |
4,952,506 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-03-09 |
4 |
B |
$71.72 |
$5,057,550 |
I/I |
70,517 |
33,217,136 |
2.25 |
% |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-17 |
4 |
B |
$7.80 |
$551,968 |
I/I |
70,757 |
7,884,702 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-23 |
4 |
B |
$4.96 |
$353,505 |
I/I |
71,278 |
244,728 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$1,964,575 |
I/I |
71,471 |
5,855,797 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-09 |
4 |
B |
$26.66 |
$1,941,654 |
I/I |
72,479 |
6,348,720 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-24 |
4 |
B |
$23.43 |
$1,700,598 |
I/I |
72,542 |
5,058,267 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-02-08 |
4 |
B |
$16.85 |
$1,230,788 |
I/I |
72,969 |
3,899,789 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-28 |
4 |
S |
$1.19 |
$88,738 |
I/I |
(74,670) |
6,698,102 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-02 |
4 |
B |
$26.00 |
$1,956,372 |
I/I |
74,969 |
5,253,682 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-01-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(75,118) |
2,258 |
0 |
- |
|
1397 Records found
|
|
Page 46 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|